Casepro SRL
Casepro reported total assets of 743,843 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jun 2026).
The score of Casepro shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +1254 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Casepro's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
- Year ended 31 Dec 2024filed on 16 Sep 2025
- Year ended 31 Dec 2022filed on 28 Sep 2023
- Year ended 31 Dec 2020filed on 27 Sep 2023
- Year ended 31 Dec 2019filed on 15 Sep 2021
Casepro's financial analysis
- Solvency-44.7%sector median: 43.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Casepro
Casepro's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0673.857.317
- VAT number
- BE0673857317
- Peppol
- Registered · 0208:0673857317 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 04 Apr 2017
- Registered office
- 1300 Wavre
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Casepro (SRL) has been based in Wavre since 2017, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net loss of 37,512 € and equity of −332,451 €; its revenue is not published. Its solvency stands at -44.7%, below the median of its sector (43.9%).
Companies similar to Casepro
Companies in the same business, of comparable size and area, outside its group.
- OneLIFE Wholesale of perfume and cosmetics Ottignies-Louvain-la-Neuve · balance sheet 797,807 €
- HEW Pharma Manufacture of pharmaceutical preparations Kalmthout · balance sheet €1.01m
- Actifar Wholesale of perfume and cosmetics Mont-Saint-Guibert · balance sheet €3.08m
- Vesale Pharma Woman Health Wholesale of pharmaceutical and medical goods Éghezée · balance sheet 62,158 €
- Alparcom Wholesale of pharmaceutical and medical goods La Hulpe · balance sheet €1.02m
- Belipharm Wholesale of pharmaceutical and medical goods Leuven · balance sheet 449,785 €
- Phytos Wholesale of pharmaceutical and medical goods Kortrijk · balance sheet 2,672 €
- Emmagenics Wholesale of pharmaceutical and medical goods Ghent · balance sheet 643,095 €
Frequently asked questions about Casepro
What is the revenue of Casepro?
Casepro files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Casepro?
In Belgium, the VAT number is the company number prefixed with BE: BE0673857317 for Casepro, if the company is VAT-registered. Its company number (CBE) is 0673.857.317.
Where is the registered office of Casepro?
According to the CBE register, the registered office of Casepro is in 1300 Wavre.
What is the equity of Casepro?
At the close of the 2025 financial year, the equity of Casepro amounts to -332,451 €, a solvency of -44.7% of total assets.
Who manages Casepro?
The register lists 3 active mandates at Casepro. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Casepro
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →